SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-23-013120
Filing Date
2023-05-08
Accepted
2023-05-08 21:42:42
Documents
2
Period of Report
2023-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1456
2 poa_watton.htm EX-24 6739
  Complete submission text file 0001437749-23-013120.txt   9713
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22045 KAREN STREET ELKHORN NE 68022
Business Address
Watton Corey Michael (Reporting) CIK: 0001975404 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36913 | Film No.: 23899710